Role of Surgery for Locally Advanced and Metastatic Renal Cell Carcinoma

Restricted access

Both locally advanced and metastatic renal cell carcinoma (RCC) present a challenge in terms of their optimal management. This article reviews the literature and evaluates the role of surgery in the treatment of advanced RCC. Surgery is the optimal treatment for locally advanced RCC and minimal, resectable, metastatic disease. Patients with metastatic disease, and some forms of locally advanced disease, may also benefit from multimodal management with local surgical therapy and systemic treatment using either immunotherapy or targeted therapy. Regardless of the disease stage, patients with locally advanced or metastatic RCC represent heterogenous patient populations with different disease characteristics and risk factors. Individualization of care in the setting of a sound oncologic framework may optimize the risk/benefit ratio within individual patient cohorts.

Correspondence: David Josephson, MD, Tower Urology at Cedars-Sinai Office Towers, 8635 W. 3rd Street, Suite 1 West, Los Angeles, CA 90048. E-mail: josephsond@towerurology.com
  • 1

    Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual. New York, NY: Springer; 2010.

  • 2

    Schreyer HH, Uggowitzer MM, Ruppert-Kohlmayr A. Helical CT of the urinary organs. Eur Radiol 2002;12:575591.

  • 3

    Mueller-Lisse UG, Mueller-Lisse UL. Imaging of advanced renal cell carcinoma. World J Urol 2010;28:253261.

  • 4

    Furniss D, Harnden P, Ali N. Prognostic factors for renal cell carcinoma. Cancer Treat Rev 2008;34:407426.

  • 5

    Lane BR, Kattan MW. Prognostic models and algorithms in renal cell carcinoma. Urol Clin North Am 2008;35:613625.

  • 6

    Han KR, Bui MH, Pantuck AJ. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. J Urol 2003;169:899903.

    • Search Google Scholar
    • Export Citation
  • 7

    Thompson RH, Leibovich BC, Cheville JC. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? J Urol 2005;173:918921.

    • Search Google Scholar
    • Export Citation
  • 8

    Ficarra V, Galfano A, Guille F. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. J Urol 2007;178:418424.

    • Search Google Scholar
    • Export Citation
  • 9

    O’Malley RL, Godoy G, Kanofsky JA. The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. J Urol 2009;18:20092017.

    • Search Google Scholar
    • Export Citation
  • 10

    Siemer S, Lehmann J, Kamradt J. Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. J Urol 2004;171:21552159.

    • Search Google Scholar
    • Export Citation
  • 11

    Yokoyama H, Tanaka M. Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy? BJU Int 2005;95:526529.

    • Search Google Scholar
    • Export Citation
  • 12

    Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969;101:297301.

  • 13

    Klatte T, Chung J, Leppert JT. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma. BJU Int 2007;99:821824.

    • Search Google Scholar
    • Export Citation
  • 14

    Jeong IG, Jeong CW, Hong SK. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma. Urology 2006;67:709712.

    • Search Google Scholar
    • Export Citation
  • 15

    Yoo C, Song C, Hong JH. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. J Urol 2008;180:486491.

    • Search Google Scholar
    • Export Citation
  • 16

    Thompson RH, Leibovich BC, Cheville JC. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol 2005;174:12181221.

    • Search Google Scholar
    • Export Citation
  • 17

    Thompson RH, Blute ML, Krambeck AE. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion. Am J Surg Pathol 2007;31:10891093.

    • Search Google Scholar
    • Export Citation
  • 18

    Phillips CK, Taneja SS. The role of lymphadenectomy in the surgical management of renal cell carcinoma. Urol Oncol 2004;22:214223.

  • 19

    Blom JH, van Poppel H, Marechal JM. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 2009;55:2834.

    • Search Google Scholar
    • Export Citation
  • 20

    Studer UE, Birkhauser FD. Lymphadenectomy combined with radical nephrectomy: to do or not to do? Eur Urol 2009;55:3537.

  • 21

    Terrone C, Guercio S, De Luca S. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 2003;91:3740.

  • 22

    Phillips E, Messing EM. Role of lymphadenectomy in the treatment of renal cell carcinoma. Urology 1993;41:915.

  • 23

    Studer UE, Scherz S, Scheidegger J. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 1990;144:243245.

    • Search Google Scholar
    • Export Citation
  • 24

    Minervini A, Lilas L, Morelli G. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int 2001;88:169172.

    • Search Google Scholar
    • Export Citation
  • 25

    Pantuck AJ, Zisman A, Dorey F. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 2003;169:20762083.

    • Search Google Scholar
    • Export Citation
  • 26

    Karakiewicz PI, Trinh QD, Bhojani N. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 2007;51:16161624.

    • Search Google Scholar
    • Export Citation
  • 27

    Canfield SE, Kamat AM, Sanchez-Ortiz RF. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol 2006;175:864869.

    • Search Google Scholar
    • Export Citation
  • 28

    Blute ML, Leibovich BC, Lohse CM. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004;94:3341.

    • Search Google Scholar
    • Export Citation
  • 29

    Wagner B, Patard JJ, Mejean A. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol 2009;55:452459.

    • Search Google Scholar
    • Export Citation
  • 30

    Moinzadeh A, Libertino JA. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol 2004;171:598601.

    • Search Google Scholar
    • Export Citation
  • 31

    Kim HL, Zisman A, Han KR. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol 2004;171:588591.

    • Search Google Scholar
    • Export Citation
  • 32

    Neves RJ, Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987;59:390395.

  • 33

    Vaidya A, Ciancio G, Soloway M. Surgical techniques for treating a renal neoplasm invading the inferior vena cava. J Urol 2003;169:435444.

  • 34

    Skinner DG, Pritchett TR, Lieskovsky G. Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Ann Surg 1989;210:387392.

    • Search Google Scholar
    • Export Citation
  • 35

    Ciancio G, Gonzolez J, Shirodkar SP. Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step description. Eur Urol 2011;59:401406.

    • Search Google Scholar
    • Export Citation
  • 36

    Pouliot F, Shuch B, Larochelle JC. Contemporary management of renal tumors with venous tumor thrombus. J Urol;184:833841.

  • 37

    Lawrentschuk N, Gani J, Riordan R. Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 2005;96:291295.

    • Search Google Scholar
    • Export Citation
  • 38

    Hallscheidt PJ, Fink C, Haferkamp A. Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation. J Comput Assist Tomogr 2005;29:6468.

    • Search Google Scholar
    • Export Citation
  • 39

    Sigman DB, Hasnain JU, Del Pizzo JJ. Real-time transesophageal echocardiography for intraoperative surveillance of patients with renal cell carcinoma and vena caval extension undergoing radical nephrectomy. J Urol 1999;161:3638.

    • Search Google Scholar
    • Export Citation
  • 40

    Zisman A, Wieder JA, Pantuck AJ. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 2003;169:909916.

    • Search Google Scholar
    • Export Citation
  • 41

    Ciancio G, Soloway M. Resection of the abdominal inferior vena cava for complicated renal cell carcinoma with tumour thrombus. BJU Int 2005;96:815818.

    • Search Google Scholar
    • Export Citation
  • 42

    Duty B, Daneshmand S. Resection of the inferior vena cava without reconstruction for urologic malignancies. Urology 2009;74:12571262.

  • 43

    Margulis V, Sanchez-Ortiz RF, Tamboli P. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management. Cancer 2007;109:20252030.

    • Search Google Scholar
    • Export Citation
  • 44

    Capitanio U, Perrotte P, Zini L. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma). BJU Int 2009;104:795799.

    • Search Google Scholar
    • Export Citation
  • 45

    Karakiewicz PI, Suardi N, Jeldres C. Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol 2008;53:845848.

    • Search Google Scholar
    • Export Citation
  • 46

    Di Silverio F, Sciarra A, Parente U. Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy. Urol Int 2008;80:451453.

    • Search Google Scholar
    • Export Citation
  • 47

    Patard JJ, Thuret R, Raffi A. Treatment with sunitinib enabled complete resection of massive lymphadenopathy not previously amenable to excision in a patient with renal cell carcinoma. Eur Urol 2009;55:237239.

    • Search Google Scholar
    • Export Citation
  • 48

    Thomas AA, Rini BI, Stephenson AJ. Surgical resection of renal cell carcinoma after targeted therapy. J Urol 2009;182:881886.

  • 49

    Thomas AA, Rini BI, Lane BR. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. J Urol 2009;181:518523.

    • Search Google Scholar
    • Export Citation
  • 50

    Paez-Ribes M, Allen E, Hudock J. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009;15:220231.

    • Search Google Scholar
    • Export Citation
  • 51

    Ebos JM, Lee CR, Cruz-Munoz W. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009;15:232239.

    • Search Google Scholar
    • Export Citation
  • 52

    Bex A, Jonasch E, Kirkali Z. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials. Eur Urol 2010; 58:819828.

    • Search Google Scholar
    • Export Citation
  • 53

    Gupta K, Miller JD, Li JZ. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 2008;34:193205.

    • Search Google Scholar
    • Export Citation
  • 54

    Rini BI, Campbell SC. The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy. J Urol 2007;177:19781984.

    • Search Google Scholar
    • Export Citation
  • 55

    Flanigan RC, Salmon SE, Blumenstein BA. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001;345:16551659.

    • Search Google Scholar
    • Export Citation
  • 56

    Mickisch GH, Garin A, van Poppel H. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001;358:966970.

    • Search Google Scholar
    • Export Citation
  • 57

    Flanigan RC, Mickisch G, Sylvester R. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 2004;171:10711076.

    • Search Google Scholar
    • Export Citation
  • 58

    Pantuck AJ, Belldegrun AS, Figlin RA. Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma. N Engl J Med 2001;345:17111712.

  • 59

    de Reijke TM, Bellmunt J, van Poppel H. EORTC-GU group expert opinion on metastatic renal cell cancer. Eur J Cancer 2009;45:765773.

  • 60

    McDermott DF. Update on the application of interleukin-2 in the treatment of renal cell carcinoma. Clin Cancer Res 2007;13:716s720s.

  • 61

    Spiess PE, Fishman MN. Cytoreductive nephrectomy vs medical therapy as initial treatment: a rational approach to the sequence question in metastatic renal cell carcinoma. Cancer Control 2010;17:269278.

    • Search Google Scholar
    • Export Citation
  • 62

    Thelen A, Jonas S, Benckert C. Liver resection for metastases from renal cell carcinoma. World J Surg 2007;31:802807.

  • 63

    Zerbi A, Ortolano E, Balzano G. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol 2008;15:11611168.

    • Search Google Scholar
    • Export Citation
  • 64

    Piltz S, Meimarakis G, Wichmann MW. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 2002;73:10821087.

    • Search Google Scholar
    • Export Citation
  • 65

    Sherry RM, Pass HI, Rosenberg SA. Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy. Cancer 1992;69:18501855.

    • Search Google Scholar
    • Export Citation
  • 66

    Kavolius JP, Mastorakos DP, Pavlovich C. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998;16:22612266.

  • 67

    Kim B, Louie AC. Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission. Arch Surg 1992;127:13431349.

    • Search Google Scholar
    • Export Citation
  • 68

    Karam JA, Rini BI, Varella L. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol 2011;185:439444.

  • 69

    Margulis V, McDonald M, Tamboli P. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol 2009;181:20442051.

    • Search Google Scholar
    • Export Citation
  • 70

    Logan T, McDermott D, Dutcher J. Exploratory analysis of the influence of nephrectomy status on temsirolimus efficacy in patients with advanced renal cell carcinoma and poor-risk features [abstract]. Presented at the 2009 Genitourinary Cancers Symposium; February 26–28, 2009; Orlando, Florida. Abstract 281.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 1 0 0
Full Text Views 135 122 0
PDF Downloads 18 18 1
EPUB Downloads 0 0 0